Mivuten 300mg. 300mg Tablet
PDF Leaflet Revision Date: 14 September 2012
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV in adults over 18 years.
Dosage (summary)
1 tablet once daily with food.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Avoid with zalcitabine
- Increased exposure with didanosine
- Renal function monitoring with nephrotoxic agents
Contraindications
- Hypersensitivity to components
- Moderate to severe renal impairment
- Pregnancy
- Lactation
- Patients < 18 years
Common side effects
- Nausea
- Vomiting
- Abdominal pain
- Fatigue
- Headache
Counselling Points
- Monitor for lactic acidosis symptoms
- Avoid alcohol
- Regular renal function tests
- Use effective contraception
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Renal impairment
- Risk of HBV exacerbation
Important Disclaimer
The Mivuten 300mg. 300mg Tablet professional information leaflet below is the property of Cipla and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
